deltatrials
Completed PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT01600755

Autologous Cell Therapy for Treatment of Fecal Incontinence

A Prospective Nonrandomized Study of Autologous Muscle Derived Cell (AMDC) Transplantation for Treatment of Fecal Incontinence

Sponsor: Cook MyoSite

Conditions Fecal Incontinence
Interventions Iltamiocel
Updated 16 times since 2017 Last updated: Jun 30, 2023 Started: Mar 28, 2013 Primary completion: Oct 27, 2021 Completion: Oct 27, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Fecal Incontinence and is currently completed. Cook MyoSite leads this study, which shows 16 recorded versions since 2013 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Aug 2017 · 6 months · monthly snapshot~Aug 2017 – ~Jun 2018 · 10 months · monthly snapshot~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshot~Sep 2018 – ~Feb 2019 · 5 months · monthly snapshot~Feb 2019 – ~Aug 2019 · 6 months · monthly snapshot~Aug 2019 – ~Jun 2020 · 10 months · monthly snapshot~Jun 2020 – ~Dec 2020 · 6 months · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~May 2021 · 4 months · monthly snapshot~May 2021 – ~Dec 2021 · 7 months · monthly snapshot~Dec 2021 – ~Jan 2022 · 31 days · monthly snapshot~Jan 2022 – ~Mar 2024 · 26 months · monthly snapshot~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

16 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  3. Mar 2024 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

  4. Jan 2022 — Mar 2024 [monthly]

    Completed PHASE1_PHASE2

    Status: Active Not Recruiting → Completed

  5. Dec 2021 — Jan 2022 [monthly]

    Active Not Recruiting PHASE1_PHASE2

▶ Show 11 earlier versions

  1. May 2021 — Dec 2021 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  2. Jan 2021 — May 2021 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  3. Dec 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  4. Jun 2020 — Dec 2020 [monthly]

    Active Not Recruiting PHASE1_PHASE2

    Status: Recruiting → Active Not Recruiting

  5. Aug 2019 — Jun 2020 [monthly]

    Recruiting PHASE1_PHASE2

  6. Feb 2019 — Aug 2019 [monthly]

    Recruiting PHASE1_PHASE2

  7. Sep 2018 — Feb 2019 [monthly]

    Recruiting PHASE1_PHASE2

  8. Jun 2018 — Sep 2018 [monthly]

    Recruiting PHASE1_PHASE2

  9. Aug 2017 — Jun 2018 [monthly]

    Recruiting PHASE1_PHASE2

  10. Feb 2017 — Aug 2017 [monthly]

    Recruiting PHASE1_PHASE2

  11. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE1_PHASE2

    First recorded

Mar 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Cook MyoSite
Data source: Cook MyoSite

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations